Myomo (MYO) Depreciation & Amortization (CF) (2025)
Myomo's (MYO) quarterly Depreciation & Amortization (CF) came in at $190798.0 in Q2 2025, up 20.42% quarter-over-quarter from $158442.0 in Q1 2025.
Powered by 
Analysis
Myomo (MYO) Depreciation & Amortization (CF) (2025) Analysis & Trends
Myomo (MYO) has reported Depreciation & Amortization (CF) for 1 consecutive years, with $190798.0 the latest figure, recorded in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 729.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 355.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 42.70 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 68.20 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | - |